Jeannett Dimsits — MD, MMBS
Board Membe

Meet Dr. Jeannett Dimsits, Board Member at Hemostatics

Dr. Jeannett Dimsits is a Medical Doctor with more than 24 years of substantial experience in clinical development, having successfully navigated roles in both large pharmaceutical corporations and dynamic biotech companies. She spent 14 years at Novo Nordisk, where she was instrumental within Clinical Development teams for Trauma and Hemostasis, notably serving as the medical lead on the pivotal Phase 3 CONTROL trial involving rFVIIa. Additionally, her professional background includes two years dedicated specifically to drug safety, emphasizing the management of critical bleeding events, building upon her foundational clinical expertise in internal medicine and cardiology.

Currently, Dr. Dimsits leads the Phase 3 clinical program at MinervaX, a Danish biotechnology firm focused on developing a maternal vaccine against Group B Streptococcus. Her role in this agile biotech environment demands versatile leadership across diverse aspects including safety monitoring, trial design, and scientific publications.

Committed to advancing patient care through innovative treatments and digital healthcare solutions, Dr. Dimsits actively seeks opportunities to enhance clinical practices and optimize patient outcomes. She is known as an ambitious, collaborative team player, setting high standards for herself and her colleagues, with a focus on achieving shared goals through collective effort.